
Faraz K Mardakheh
@fkhm
Associate Professor at the Department of Biochemistry, University of Oxford. Studying RNA binding proteins in cancer.
mardakhehlab.info
ID: 48317154
https://bioch.web.ox.ac.uk/research/mardakheh 18-06-2009 11:10:44
2,2K Tweet
1,1K Takipçi
1,1K Takip Edilen

Into (r)RNA modifications? Check out the new review article by Eva Maria Novoa and me, out today in Trends Cell Biology!





It's our great pleasure to share our work on the role of CADASIL NOTCH3 mutations in the development of DNMT3A-related Clonal Hematopoiesis. Published now in Leukemia Journal Huge congrats to Raúl Sánchez-Lanzas!!! Many thanks to Leukaemia UK Medical Research Council nature.com/articles/s4137…


Excited to share our latest work published in collaboration with Huakun Zhang’s group on how RNA structure regulates subgenomic RNA decay in wheat Building Robustness in Crops John Innes Centre Haopeng Yu nature.com/articles/s4146…



Johnny Yu, Nima Alidoust, Kevan Shokat, and I are excited to announce a historic achievement by our team at Vevo Therapeutics: Tahoe-100M, a 100M single-cell transcriptomic atlas, measuring how thousands of drugs impact cells from 50 diverse cancer lines. prnewswire.com/news-releases/…


Our latest from the indefatigable Johnny Yu in collaboration with Jonathan Weissman's Lab and Kevan Shokat. Meet GENEVA, which enables simultaneous phenotyping and profiling of cancer cell drug responses at scale; both in vitro and in vivo across a variety of models: biorxiv.org/content/10.110…


The Barr lab Department of Biochemistry at Oxford University has discovered the important role of cell division timing mechanisms in the formation of cancer. The research, funded by Cancer Research UK, provides valuable insight into how damaged cells are normally stopped from growing. ⬇️bit.ly/202502-barr



[3/5] Faraz Mardakheh received a Programme Foundation Award to uncover the mechanisms behind malignant dysregulation of ribosome biogenesis & its impact on tumorigenesis to identify novel cancer-specific therapeutic targets. Faraz K Mardakheh | Queen Mary University of London | University of Oxford | #CRUKFunded
![Science and Innovation at Cancer Research UK (@crukresearch) on Twitter photo [3/5]
Faraz Mardakheh received a Programme Foundation Award to uncover the mechanisms behind malignant dysregulation of ribosome biogenesis & its impact on tumorigenesis to identify novel cancer-specific therapeutic targets.
<a href="/FKHM/">Faraz K Mardakheh</a> | <a href="/QMUL/">Queen Mary University of London</a> | <a href="/UniofOxford/">University of Oxford</a> | #CRUKFunded [3/5]
Faraz Mardakheh received a Programme Foundation Award to uncover the mechanisms behind malignant dysregulation of ribosome biogenesis & its impact on tumorigenesis to identify novel cancer-specific therapeutic targets.
<a href="/FKHM/">Faraz K Mardakheh</a> | <a href="/QMUL/">Queen Mary University of London</a> | <a href="/UniofOxford/">University of Oxford</a> | #CRUKFunded](https://pbs.twimg.com/media/GlNhq3VXkAA8SYd.jpg)


Happy to share our new work with Hao Nguyen on targeting mRNA translation of oncogenes by RNA structure remodeling with a small molecule zotatifin. Congrats to Duygu Kuzuoglu Ozturk an amazing postdoc and all the authors and collaborators! cell.com/cancer-cell/fu…